1-Alciati G, Fedeli M., Pesce Delfino V. 1987, “La malattia dalla preistoria all’età antica”, Laterza Ed. Roma-Bari. Amini F., Safari A. et al. 2007, “A cephalometric study on craniofacial morphology of Iranian children with beta-thalassemia major”, Orthod Craniofac Res, 10(1): 36-44.
2-Ali T. Tahera, Zaher K. Otrock, ImadUthman, Maria D. Cappellini.Thalassemia and Hypercoagulability.Blood Reviews 2008; 22: 283–292.
3-Bain Borbara J. Hemoglobinopathy diagnosis. UK: Blackwell Science Ltd; 2000.
4-Bichard G, Bitell TC, Fcerster J, Athon JW, Lukens JNO: Pregnancy in hemogobines S and sickling syndrome wintorbe, s clinical Hematology 9th(ed) lea and febger publisher, 1993 : 1075-1085
5-Clarke GM, Higgins TN. Laboratory investigation ofhemoglobinapathies and thalassemia; review andupdate. Clinical Chemistry 2000; 46(8): 1284-1290.
6-Dacie, Sir John V. Lewis, SM. Practical haematology. 6th ed. Carchill Levingntone Edinburgh; 1984.11-A. Taher Et Al; Blood Cells, Molecules, And Diseases 37(2006) 12–20
7-Drousiotou A. Globin chain synthesis and separationon CMC columns, for adult and foetal samples.Techniques in the Diagnosis and Monitoring of Thalassemia, A Laboratory Manual, 1999; Nicosia-Cyprus.
8-Galanello R, Satta S, Pirroni MG, Tari M, Maccioni L. Globin chain synthesis analysis by high performance liquid chromatoghraphy in the screening of thalassemia syndromes. Hemoglobin 1998 Sep-Nov; 22(5,6): 501-508.
9-Goossens JP, Statius van Eps LW, Schouten H. GietersonAL: Incomplete renal tubular acidosis in sickle cell disease. ClinChimActa 1972; 41: 149-156.
10-Haghshenas N, Esmail Beigi fmclegg JB:Milad sicjit cell anemia in iran is associated with high level of fetal hemogolobin J Med Genet 14. 168 19.
11-HosseiniGohari L, Petrou M, Felekis X, ChristopoulosG, Kleanthous M. Identification of _-thalassemiamutation in Iranian Individuals with abnormal hematotogical indices and normal HbA2. Hemoglobin 2002; 27(2): 129-132.
12-Matthewson Beryl E, Gray GR. Evaluation of achromatographic method for globin chain biosynthesisin thalassemia. Journal of Clinical Biochemistry 1983;16(3): 167-170.
13-NajmabadiH, GhamariA, SahebjamF, KariminejadR, HadiviV, KtibiT, "etal". Fourteen-year experience of prenatal diagnosis of thalassemia in iran. Community Genetics 2006; 9: 93-7.
14-Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, "et al". The thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001; 25(3): 285-96.
15-Neishabury M, Oberkanins C, Moheb LA, Pourfathollah AA, Kahrizi E, "et al". High prevalence of the alpha 3.7 deletion among thalassemia patients in iran. Hemoglobin 2003; 27: 53-5.
16-Samavat A, Modell B. Iranian national thalassameia screening programme.
BMJ 2004 Nov; 329(7475): 1134-7.
17-Thalassemia prevention program in Iran. TIF Magazine 2002; 35: 13-15.
18-Weatherall DJ, Clegg JB. The thalassemia syndromes.3rd ed. Oxford: Blackwell scientific publications; 1981.
19-Weatherall DJ. The thalassemias InStamatoyannopoulos Iranian province of Hormozgan Hemogolobin 2001; 25: 35-43.
20-Yavarian M, Karimi M, Zoari A, Harteveld CL, Giordano PC. Molecular basis of HbH disease of Southwest Iran. Hemoglobin 2005; 29: 43-50.
)